Barr laboratories inc barr appeals the district courts grant of summary judgment interpreting the hatch waxman amendments of the federal food drug and cosmetic act 21 usc 301 et seq and regulations promulgated thereunder 21 cfr 31494 314107 to pharmachemie bv a potential competitor of barrs barr contends . Drug companys appeal in action for enforcement of generic exclusivity was moot and subject to dismissal where competitor lost patent suit against original manufacturer and thus could not . A global leader in the pharmaceutical industries developing producing and marketing affordable high quality generic drugs and specialty pharmaceuticals. Pharmachemie bv appellee v barr laboratories inc appellant 276 f3d 627 dc cir 2002 case opinion from the us court of appeals for the district of . Zeneca ltd v pharmachemie bv order oct 27 2000 ii pharmachemie contends that the case is moot on appeal because it can no longer obtain the relief it sought in its complaint in light of the adverse final judgment on the validity of the patent
How it works:
1. Register a Free 1 month Trial Account.
2. Download as many books as you like ( Personal use )
3. No Commitment. Cancel anytime.
4. Join Over 100.000 Happy Readers.
5. That's it. What you waiting for? Sign Up and Get Your Books.